Castle Rock Wealth Management LLC Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Castle Rock Wealth Management LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 72.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 713 shares of the healthcare conglomerate's stock after selling 1,861 shares during the period. Castle Rock Wealth Management LLC's holdings in UnitedHealth Group were worth $373,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in UNH. Probity Advisors Inc. lifted its stake in UnitedHealth Group by 45.2% in the fourth quarter. Probity Advisors Inc. now owns 848 shares of the healthcare conglomerate's stock valued at $429,000 after acquiring an additional 264 shares during the last quarter. Dogwood Wealth Management LLC lifted its position in shares of UnitedHealth Group by 42.3% in the fourth quarter. Dogwood Wealth Management LLC now owns 1,215 shares of the healthcare conglomerate's stock valued at $615,000 after buying an additional 361 shares during the last quarter. Buska Wealth Management LLC raised its stake in UnitedHealth Group by 11.9% in the 4th quarter. Buska Wealth Management LLC now owns 1,471 shares of the healthcare conglomerate's stock valued at $744,000 after acquiring an additional 156 shares during the period. BridgePort Financial Solutions LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $720,000. Finally, Park Square Financial Group LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at about $402,000. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $0.01 on Thursday, hitting $298.11. 16,213,440 shares of the company traded hands, compared to its average volume of 6,746,323. The company has a market cap of $270.42 billion, a P/E ratio of 19.23, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The firm's 50-day simple moving average is $439.50 and its 200 day simple moving average is $498.65.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. KeyCorp dropped their price target on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Oppenheimer reduced their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their price target for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Robert W. Baird cut their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $441.87.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.